Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A multipurpose vaginal ring has shown promise in protecting against HIV, genital herpes, HPV and pregnancy in a primate study.
Women who regularly used a Viread (tenofovir)–based vaginal gel had a 46 percent reduced risk of acquiring herpes simplex virus type 2.
Pre-exposure prophylaxis (PrEP) to prevent getting HIV may also lower the risk of contracting herpes.
Infection with herpes simplex virus 2 is propelling significant increases in the prevalence of HIV among non-injecting drug users in New York...
The CDC estimates that there are 20 million new sexually transmitted infections in the US each year, with a price tag of $16 billion.
People taking the antiretroviral (ARV) drug tenofovir (found in Viread, Truvada and Atripla) as part of their HIV treatment regimen had no bet...
An experimental vaccine failed to protect HIV-negative women from developing genital herpes, according to a statement by the National Institut...
Treating herpes does not help prevent HIV transmission.
Treating herpes simplex 2 (HSV-2) in HIV-positive people does not reduce the risk of transmitting HIV to their sexual partners, according to s...
Acyclovir doesn’t prevent HIV-positive people from transmitting the virus to their uninfected partners, but it does appear to slow HIV disease...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.